Importer of Controlled Substances Application: Chattem Chemicals, 2578 [2019-01512]
Download as PDF
<![CDATA[
2578
Federal Register / Vol. 84, No. 26 / Thursday, February 7, 2019 / Notices
a hearing after the ALJ granted the
Government’s Motion for Summary
Disposition and recommended
revocation of Respondent’s registration.
Motion, at 1. The Motion also states
that, as a result of the hearing, the Texas
Medical Board suspended Respondent’s
medical license, ordered that the
suspension be stayed, and placed
Respondent on five years’ probation
under various terms and conditions. Id.
The Motion concludes by stating that,
‘‘Since . . . [Respondent] now has state
authority to handle controlled
substances, the DEA respectfully
request[s] the Administrator to dismiss
the pending Order to Show Cause and
recommended ruling from the
Administrative Law Judge.’’ Id. at 2.
Accordingly, I shall dismiss the Order to
Show Cause.
Order
Pursuant to 28 CFR 0.100(b) and the
authority thus vested in me by 21 U.S.C.
823(f) and 824(a), I order that the Order
to Show Cause issued to Kurt L.
Pflieger, M.D. be, and it hereby is,
dismissed. This Order is effective March
11, 2019.
Dated: January 17, 2019.
Uttam Dhillon,
Acting Administrator.
[FR Doc. 2019–01528 Filed 2–6–19; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]
Importer of Controlled Substances
Application: Chattem Chemicals
ACTION:
Notice of application.
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before March 11, 2019. Such persons
may also file a written request for a
hearing on the application on or before
March 11, 2019.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for hearing must be
sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152. All requests for hearing
should also be sent to: (1) Drug
Enforcement Administration, Attn:
Hearing Clerk/OALJ, 8701 Morrissette
Drive, Springfield, Virginia 22152; and
(2) Drug Enforcement Administration,
Attn: DEA Federal Register
DATES:
Representative/DPW, 8701 Morrissette
Drive, Springfield, Virginia 22152.
The
Attorney General has delegated his
authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
respect to the promulgation and
implementation of 21 CFR part 1301,
incident to the registration of
manufacturers, distributors, dispensers,
importers, and exporters of controlled
substances (other than final orders in
connection with suspension, denial, or
revocation of registration) has been
redelegated to the Assistant
Administrator of the DEA Diversion
Control Division (‘‘Assistant
Administrator’’) pursuant to section 7 of
28 CFR part 0, appendix to subpart R.
In accordance with 21 CFR
1301.34(a), this is notice that on October
31, 2018, Chattem Chemicals Inc., 3801
Saint Elmo Avenue, Chattanooga,
Tennessee 37409–1237 applied to be
registered as an importer of the
following basic classes of controlled
substances:
SUPPLEMENTARY INFORMATION:
Drug
code
Controlled substance
Methamphetamine ...................................................................................................................................................................
4-Anilino-N-phenethyl-4-piperidine (ANPP) .............................................................................................................................
Phenylacetone .........................................................................................................................................................................
Opium, raw ..............................................................................................................................................................................
Poppy Straw Concentrate .......................................................................................................................................................
Tapentadol ...............................................................................................................................................................................
The company plans to import the
listed controlled substances to
manufacture bulk controlled substances
for sale to its customers.
The company plans to import an
intermediate of tapentadol (9780), to
bulk manufacture tapentadol for
distribution to its customers.
DEPARTMENT OF JUSTICE
Dated: December 21, 2018.
John J. Martin,
Assistant Administrator.
ACTION:
Drug Enforcement Administration
[Docket No. DEA–392]
Bulk Manufacturer of Controlled
Substances Registration
Notice of registration.
Registrants listed below have
applied for and been granted a
registration by the Drug Enforcement
Administration (DEA) as bulk
SUMMARY:
[FR Doc. 2019–01512 Filed 2–6–19; 8:45 am]
BILLING CODE 4410–09–P
The
companies listed below applied to be
registered as bulk manufacturers of
various basic classes of controlled
substances. Information on previously
published notices are listed in the table
below. No comments or objections were
submitted for these notices.
SUPPLEMENTARY INFORMATION:
FR
Docket
National Center for Natural Products Research NIDA MPROJECT ............................................................
Halo Pharmaceutical, Inc ..............................................................................................................................
Nanosyn, Inc .................................................................................................................................................
83 FR 48334
83 FR 48334
83 FR 48867
17:23 Feb 06, 2019
Jkt 247001
PO 00000
Frm 00092
Fmt 4703
Sfmt 4703
II
II
II
II
II
II
manufacturers of various classes of
schedule I and II controlled substances.
Company
VerDate Sep<11>2014
1105
8333
8501
9600
9670
9780
Schedule
E:\FR\FM\07FEN1.SGM
07FEN1
Published
August 31, 2018.
September 24, 2018.
September 27, 2018.
]]>Agencies
[Federal Register Volume 84, Number 26 (Thursday, February 7, 2019)]
[Notices]
[Page 2578]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-01512]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-392]
Importer of Controlled Substances Application: Chattem Chemicals
ACTION: Notice of application.
-----------------------------------------------------------------------
DATES: Registered bulk manufacturers of the affected basic classes, and
applicants therefore, may file written comments on or objections to the
issuance of the proposed registration on or before March 11, 2019. Such
persons may also file a written request for a hearing on the
application on or before March 11, 2019.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/DPW,
8701 Morrissette Drive, Springfield, Virginia 22152. All requests for
hearing must be sent to: Drug Enforcement Administration, Attn:
Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All
requests for hearing should also be sent to: (1) Drug Enforcement
Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive,
Springfield, Virginia 22152; and (2) Drug Enforcement Administration,
Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive,
Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: The Attorney General has delegated his
authority under the Controlled Substances Act to the Administrator of
the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority
to exercise all necessary functions with respect to the promulgation
and implementation of 21 CFR part 1301, incident to the registration of
manufacturers, distributors, dispensers, importers, and exporters of
controlled substances (other than final orders in connection with
suspension, denial, or revocation of registration) has been redelegated
to the Assistant Administrator of the DEA Diversion Control Division
(``Assistant Administrator'') pursuant to section 7 of 28 CFR part 0,
appendix to subpart R.
In accordance with 21 CFR 1301.34(a), this is notice that on
October 31, 2018, Chattem Chemicals Inc., 3801 Saint Elmo Avenue,
Chattanooga, Tennessee 37409-1237 applied to be registered as an
importer of the following basic classes of controlled substances:
------------------------------------------------------------------------
Controlled substance Drug code Schedule
------------------------------------------------------------------------
Methamphetamine....................... 1105 II
4-Anilino-N-phenethyl-4-piperidine 8333 II
(ANPP).
Phenylacetone......................... 8501 II
Opium, raw............................ 9600 II
Poppy Straw Concentrate............... 9670 II
Tapentadol............................ 9780 II
------------------------------------------------------------------------
The company plans to import the listed controlled substances to
manufacture bulk controlled substances for sale to its customers.
The company plans to import an intermediate of tapentadol (9780),
to bulk manufacture tapentadol for distribution to its customers.
Dated: December 21, 2018.
John J. Martin,
Assistant Administrator.
[FR Doc. 2019-01512 Filed 2-6-19; 8:45 am]
BILLING CODE 4410-09-P
